Protracted complete response after limited checkpoint inhibitor dosing: A case report

Quinne Sember1, Darren Sigal1

  • 1Scripps Health San Deigo California USA.

Clinical Case Reports
|October 6, 2023
PubMed
Summary

Immunotherapy, such as pembrolizumab, can lead to long-term complete responses in metastatic gastric cancer. Further research is needed to identify patients who can benefit from fewer treatments, reducing side effects and costs.

Related Concept Videos